about
Using N-of-1 trials to improve patient management and save costsSex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D TrialImproving the physician-patient cardiovascular risk dialogue to improve statin adherence.The RISAP-study: a complex intervention in risk communication and shared decision-making in general practiceThe impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.Patients' perspectives on nonadherence to statin therapy: a focus-group study.Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.Improving medication adherence in hypercholesterolemia: challenges and solutions.Effects of Physician Communication and Family Hardiness on Patient Medication Regimen Beliefs and Adherence.The roles of past behavior and health beliefs in predicting medication adherence to a statin regimenThe significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed populationAre intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related).A systematic review to assess adherence and persistence with statins.Prescriber and pharmacy variation in patient adherence to five medication classes measured using implementation during persistent episodes.A simple informative intervention in primary care increases statin adherence.Mitigation of statins-induced cytotoxicity and mitochondrial dysfunction by L-carnitine in freshly-isolated rat hepatocytes.A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial.The importance of cholesterol medication adherence: the need for behavioral change intervention programs.
P2860
Q24594944-31C6D2FB-AAAE-4CA5-9FB3-90EA35664644Q30405816-CEA8BCB4-1314-4047-BDD0-8E9066F864D0Q33476545-BED69C64-9C77-4448-9A03-09B9192E08F8Q33699363-7B54E4AF-D26B-45B6-91B4-3AE1492E56B5Q33892516-BB20F20F-2AC2-42AA-8CAA-F08F69E9CF53Q34030812-14B23618-0721-43F2-B3C8-F11EDEB89CC5Q34366183-6DA31CB1-F020-4381-9DCF-D71710629E76Q34482456-571835E2-23E6-4E4B-91DF-27FF876409B4Q34938270-8218E7A1-F46C-45D9-8D27-998E0473CA84Q36289295-9EA6A914-A5F8-477B-BBDA-60D7FB5475E4Q36432150-8C505A3C-50D6-4B22-B1EA-753D43D2F808Q37218063-4306B73D-A83F-44F9-B76E-6BCC0D85AA38Q37454427-CD4FDCED-6D74-4856-ABE3-959D569519D0Q37611803-22DDBE60-91D2-4583-A082-1F54D3F055CBQ38867559-668026A5-3E34-41F1-9355-8BDDB297B13AQ39026831-161FBEA7-BDC2-46EE-A5A8-1D5EE31CDF4AQ39770404-9CDD31FE-1302-4CAD-BA7B-4AC7F92DB509Q40327063-FED0FB32-E353-4B92-BFBF-523F0DF882FBQ42187203-847AD55B-68A8-42E6-BF5F-C05D280BE883Q45913969-8EE4F795-AFCC-4858-AE0D-9BC72DC9AA41Q53428968-2CE379EB-79B9-4E9E-BDAF-FCA240F3D9AB
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Medication adherence trends with statins.
@en
Medication adherence trends with statins.
@nl
type
label
Medication adherence trends with statins.
@en
Medication adherence trends with statins.
@nl
prefLabel
Medication adherence trends with statins.
@en
Medication adherence trends with statins.
@nl
P2093
P356
P1433
P1476
Medication adherence trends with statins.
@en
P2093
Michelle A Huser
Tamara S Evans
Val Berger
P2888
P304
P356
10.1007/BF02849887
P407
P577
2005-03-01T00:00:00Z